QURE uniQure NV
Price (delayed)
$13.798
Market cap
$746.15M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$4.92
Enterprise value
$1.09B
uniQure is delivering on the promise of gene therapy - single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline
Highlights
The gross margin has soared by 131% year-on-year
The quick ratio has soared by 51% since the previous quarter and by 10% year-on-year
The company's revenue has surged by 71% YoY but it fell by 5% QoQ
The equity has shrunk by 112% QoQ and by 103% YoY
Key stats
What are the main financial stats of QURE
Market
Valuations
Earnings
Shares outstanding
54.08M
Market cap
$746.15M
Enterprise value
$1.09B
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
24.75
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
40.13
Revenue
$27.12M
Gross profit
$8.79M
Operating income
-$184.29M
Net income
-$239.56M
EBIT
-$173.39M
EBITDA
-$160.75M
Free cash flow
-$194.42M
Per share
Balance sheet
Liquidity
EPS
-$4.92
EPS diluted
-$4.92
Free cash flow per share
-$4
Book value per share
-$0.14
Revenue per share
$0.56
TBVPS
$9.52
Total assets
$556.54M
Total liabilities
$563.29M
Debt
$500.99M
Equity
-$6.75M
Working capital
$350.24M
Debt to equity
-74.2
Current ratio
9.74
Quick ratio
9.32
Net debt/EBITDA
-2.13
Margins
Efficiency
Dividend
EBITDA margin
-592.7%
Gross margin
32.4%
Net margin
-883.4%
Operating margin
-679.6%
Return on assets
-35.4%
Return on equity
-327.1%
Return on invested capital
-21.6%
Return on capital employed
-33.6%
Return on sales
-639.4%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
QURE stock price
How has the uniQure stock price performed over time
Intraday
3.43%
1 week
10.3%
1 month
4.14%
1 year
170.02%
YTD
-21.87%
QTD
-21.87%
Financial performance
How have uniQure's revenue and profit performed over time
Revenue
$27.12M
Gross profit
$8.79M
Operating income
-$184.29M
Net income
-$239.56M
Gross margin
32.4%
Net margin
-883.4%
The gross margin has soared by 131% year-on-year
The company's revenue has surged by 71% YoY but it fell by 5% QoQ
The operating margin has soared by 62% YoY and by 3% from the previous quarter
The net margin has soared by 55% YoY but it fell by 5% QoQ
Growth
What is uniQure's growth rate over time
Valuation
What is uniQure stock price valuation
P/E
N/A
P/B
N/A
P/S
24.75
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
40.13
The company's EPS rose by 24% YoY
The equity has shrunk by 112% QoQ and by 103% YoY
The company's revenue has surged by 71% YoY but it fell by 5% QoQ
The P/S is 61% lower than the 5-year quarterly average of 60.6 but 56% higher than the last 4 quarters average of 15.3
Efficiency
How efficient is uniQure business performance
The return on equity has dropped by 73% since the previous quarter
The company's return on sales has surged by 62% YoY but it fell by 7% QoQ
The return on invested capital has increased by 34% year-on-year but it has declined by 9% since the previous quarter
The ROA has contracted by 10% from the previous quarter but it has grown by 6% YoY
Dividends
What is QURE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for QURE.
Financial health
How did uniQure financials performed over time
The quick ratio has soared by 51% since the previous quarter and by 10% year-on-year
The current ratio has grown by 50% from the previous quarter and by 10% YoY
The equity has shrunk by 112% QoQ and by 103% YoY
The debt fell by 6% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.